==== Reference: Usmani SS, Bedi G, Samuel JS, Singh S, Kalra S, Kumar P, et al. (2017) THPdb: Database of FDA-approved peptide and protein therapeutics. PLoS ONE 12(7) e0181748.====

Browse result page of THPdb

The total number entries retrieved from this search are 1
ID1454ThPPIDTh1084NameBecaplerminPeptide SequenceSLGSLTIAEPAMIAECKTRT Full viewLength109Functional ClassificationIbDiseaseCardiacBrandREGRANEXCompanyOMJ Pharmaceuticals, Inc. San German, Puerto RicoPhysical AppearanceGel: 0.01 %; clear, colorless to straw-colored gelRoute of AdministartionExternal use onlyCategoryAngiogenesis Inducing Agents TargetT-cell surface glycoprotein CD1a,Major histocompatibility complex class I-related gene protein,Integrin alpha-L,T-lymphocyte activation antigen CD86,Low affinity immunoglobulin gamma Fc region receptor II-b,T-cell surface glycoprotein CD4,Integrin beta-1,Integrin alpha-V,Integrin beta-3